Molecule Information
General Information of the Molecule (ID: Mol04214)
| Name |
Phosphorylated extracellular signal-regulated kinases 1/2 (p-ERK1/2)
,Homo sapiens
|
||||
|---|---|---|---|---|---|
| Synonyms |
Phosphorylated extracellular signal-regulated kinases 1/2 (p-ERK1/2)
Click to Show/Hide
|
||||
| Molecule Type |
Protein
|
||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Investigative Drug(s)
1 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Lung adenocarcinoma [ICD-11: 2C25.0] | [1] | |||
| Resistant Disease | Lung adenocarcinoma [ICD-11: 2C25.0] | |||
| Resistant Drug | Astragaloside IV | |||
| Molecule Alteration | Expression | Down-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| Cell Pathway Regulation | EREG/ErbB/ERK signalling pathway | Regulation | N.A. | |
| In Vitro Model | A549/TR cells | Epithelium | Homo sapiens (Human) | CVCL_C5S0 |
| Experiment for Molecule Alteration |
Western blot assay | |||
| Experiment for Drug Resistance |
Sphere-forming assay; CCK8 assay | |||
| Mechanism Description | ASIV reversed taxol resistance through suppression of the stemness-associated genes of spheres in NSCLC. The mechanism exploration revealed that ASIV promoted the K48-linked polyubiquitination of EREG along with degradation. Moreover, EREG could be triggered by chemo-drug treatment. Consequently, EREG bound to the ErbB receptor and activated the ERK signal to regulate the expression of the stemness-associated genes. Inhibition of EREG/ErbB/ERK could reverse the taxol-resistance by inhibiting the stemness-associated genes. | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
